Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy.
Villanueva V, Bermejo P, Montoya J, Massot-Tarrús A, Galiano ML, Toledo M, Rodriguez-Uranga JJ, Bertol V, Mauri JÁ, Poza JJ, Bonet M, Castro-Vilanova MD, Ruiz-Giménez J, López-González FJ, Rodríguez-Osorio X, Tortosa-Conesa D, Ojeda J, Giner P, Garcés M, Alvarez BM, Quiroga-Subirana P, Esteve P, Baiges JJ, Hampel K. Villanueva V, et al. Among authors: bermejo p. Epilepsy Behav. 2019 Aug;97:51-59. doi: 10.1016/j.yebeh.2019.05.003. Epub 2019 Jun 7. Epilepsy Behav. 2019. PMID: 31181429
Early add-on lacosamide in a real-life setting: results of the REALLY study.
Villanueva V, Garcés M, López-Gomáriz E, Serratosa JM, González-Giráldez B, Parra J, Rodríguez-Uranga J, Toledo M, López González FJ, Bermejo P, Giner P, Castillo A, Molins A, Campos D, Mauri JÁ, Muñoz R, Bonet M, Serrano-Castro P, del Villar A, Saiz-Díaz RA; REALLY Study Group. Villanueva V, et al. Among authors: bermejo p. Clin Drug Investig. 2015 Feb;35(2):121-31. doi: 10.1007/s40261-014-0255-5. Clin Drug Investig. 2015. PMID: 25488477
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
Villanueva V, Bermejo P, Montoya J, Toledo M, Gómez-Ibáñez A, Garcés M, Vilella L, López-González FJ, Rodriguez-Osorio X, Campos D, Martínez P, Giner P, Zurita J, Rodríguez-Uranga J, Ojeda J, Mauri JA, Camacho JL, Ruiz-Giménez J, Poza JJ, Massot-Tarrús A, Galiano ML, Bonet M. Villanueva V, et al. Among authors: bermejo p. Acta Neurol Scand. 2017 Sep;136(3):254-264. doi: 10.1111/ane.12720. Epub 2016 Dec 9. Acta Neurol Scand. 2017. PMID: 27935017
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: Experience from a multicenter, observational study.
Toledano R, Jovel CE, Jiménez-Huete A, Bayarri PG, Campos D, Gomariz EL, Giráldez BG, García-Morales I, Falip M, Agredano PM, Palao S, Prior MJAA, Pascual MRQ, Navacerrada FJ, González FJL, Ojeda J, Sáez AA, Bermejo PE, Gil-Nagel A. Toledano R, et al. Epilepsy Behav. 2017 Aug;73:173-179. doi: 10.1016/j.yebeh.2017.02.028. Epub 2017 Jun 20. Epilepsy Behav. 2017. PMID: 28641170
Consensus statement for the management of generalized tonic-clonic seizures in Spain.
Gil-Nagel A, Álvarez Carriles J, Bermejo P, Carreño M, García-Morales I, García Peñas JJ, López-González FJ, Ruíz-Falcó M, Sánchez JC, Tato C. Gil-Nagel A, et al. Among authors: bermejo p. Acta Neurol Scand. 2020 Jan;141(1):22-32. doi: 10.1111/ane.13169. Epub 2019 Oct 21. Acta Neurol Scand. 2020. PMID: 31529468 Review.
Perampanel as adjuvant treatment in epileptic encephalopathies: A multicenter study in routine clinical practice.
Alonso-Singer P, Aguilar-Amat Prior MJ, Oliva-Navarro J, Massot-Tarrús A, Giráldez BG, Bermejo P, DeToledo-Heras M, Aledo-Serrano Á, Martínez-Cayuelas E, Tirado-Requero P, Velázquez-Fragua R, López-Sobrino G, Ojeda J. Alonso-Singer P, et al. Among authors: bermejo p. Epilepsy Behav. 2022 Sep;134:108836. doi: 10.1016/j.yebeh.2022.108836. Epub 2022 Jul 20. Epilepsy Behav. 2022. PMID: 35870432
162 results